Publications of Udo Reichl
All genres
Poster (354)
661.
Poster
Influenza A Virus Chimeric OP7 Defective Interfering Particles: Cell Culture-based Production and In Vivo Antiviral Efficacy. 32nd Annual Meeting of the Society for Virology (GFV), Ulm (Germany) (2023)
662.
Poster
Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviral. 8th European Congress of Virology, Gdańsk (Poland) (2023)
663.
Poster
Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7. 32nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)
664.
Poster
Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral. 17th Vaccine Congress, Glasgow (Scotland) (2023)
665.
Poster
Platform for the scalable synthesis of human milk oligosaccharides. The Origins and Benefits of Biologically Active Components in Human Milk Conference, Florida, USA (2023)
666.
Poster
Development of a packed foam bed bioreactor for biological methanation. 6th International Conference on Monitoring and Control of Anaerobic Digestion Processes, Leipzig, Germany (2023)
667.
Poster
Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme Cascade. GlycoBioTec 2023, Berlin, Germany (2023)
668.
Poster
New avenues for human blood plasma biomarker discovery via improved in-depth analysis of the low-abundant N-Glycoproteome. GlycoBioTec 2023, Berlin, Germany (2023)
669.
Poster
In vitro multi-enzyme cascades for the synthesis of nucleotide sugars. INTERfaces Conference on ‘Intensifying Biocatalytic Processes – From Enzyme and Material Design to Industrial Applications’ (IBPRO2022), Bielefeld, Germany (2022)
670.
Poster
Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. 27th ESACT Meeting, Lisbon (Portugal) (2022)
671.
Poster
Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processes. Vaccine Technology VIII, Sitges (Spain) (2022)
672.
Poster
Towards the production of a fusogenic oncolytic rVSV-NDV virus in perfusion mode. 27th ESACT Meeting, Lisbon (Portugal) (2022)
673.
Poster
Production of a fusogenic oncolytic VSV-NDV virus: cell-line screening and process development in small-scale suspension cultures. Advancing Manufacture of Cell and Gene Therapies VII, Coronado, CA (USA) (2022)
674.
Poster
Production of influenza A virus-derived defective interfering particles for antiviral therapy in a high cell density perfusion cultivation. 27th ESACT Meeting, Lisbon (Portugal) (2022)
675.
Poster
Establishment of a click chemistry-based method for detection and characterizationof phage-host systems in anaerobic digestion. 2nd German Phage Symposium, Stuttgart, Germany (2022)
676.
Poster
Combined metagenomics and metaproteomics for analysis of the microbial community in a two-stage biogas plant. XIV Annual Congress of the European Proteomic Association, Leipzig, Germany (2022)
677.
Poster
In-vitro multi-enzyme cascades for the synthesis of UDP-galactose and UDP-N-acetylglucosamine. 32nd Joint Glycobiology Meeting, Utrecht, The Netherlands (2022)
678.
Poster
In-vitro multi-enzyme cascades for the synthesis of UDP-galactose and UDP-N-acetylglucosamine. 10th International Congress on Biocatalysis (Biocat2022), Hamburg, Germany (2022)
679.
Poster
Power to gas: Impact of changes in H2 supply on performance and microbial community composition of a biological methanation process. Himmelfahrtstagung on Bioprocess Engineering 2022 - Future Bioprocesses for a Sustainable Industry (DECHEMA), Mainz, Germany (2022)
680.
Poster
Development of a tubular foam bioreactor for biological methanation. 8th International Conference on Renewable Energy Gas Technology (REGATEC 2022), Malmö, Sweden (2022)